Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease

BACKGROUND: Among individuals with atherosclerotic cardiovascular disease (ASCVD), type 2 diabetes mellitus (T2DM) is common and confers increased risk for morbidity and mortality. Differentiating risk is key to optimize efficiency of treatment selection. Our objective was to develop and validate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, Susanna R., Segar, Matthew W., Pandey, Ambarish, Lokhnygina, Yuliya, Green, Jennifer B., McGuire, Darren K., Standl, Eberhard, Peterson, Eric D., Holman, Rury R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420281/
https://www.ncbi.nlm.nih.gov/pubmed/36030198
http://dx.doi.org/10.1186/s12933-022-01603-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420281/
https://www.ncbi.nlm.nih.gov/pubmed/36030198
http://dx.doi.org/10.1186/s12933-022-01603-8

Ejemplares similares